Canton Strategic Holdings Inc (CNTN)
CNTN Stock Price Chart
Explore Canton Strategic Holdings Inc interactive price chart. Choose custom timeframes to analyze CNTN price movements and trends.
CNTN Company Profile
Discover essential business fundamentals and corporate details for Canton Strategic Holdings Inc (CNTN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Mar 2024
Employees
2.00
Website
https://www.cantonstrategic.comCEO
Mark Wendland
Description
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
CNTN Financial Timeline
Browse a chronological timeline of Canton Strategic Holdings Inc corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 May 2026
EPS came in at -$0.17 .
Earnings released on 31 Mar 2026
EPS came in at -$2.02 falling short of the estimated -$0.42 by -380.95%.
Earnings released on 12 Nov 2025
EPS came in at -$0.34 surpassing the estimated -$0.43 by +20.93%.
Earnings released on 14 Aug 2025
EPS came in at -$0.64 falling short of the estimated -$0.58 by -10.34%.
Earnings released on 12 May 2025
EPS came in at -$0.99 falling short of the estimated -$0.84 by -17.86%.
Earnings released on 25 Mar 2025
EPS came in at -$2.02 falling short of the estimated -$1.53 by -32.03%.
Earnings released on 7 Nov 2024
EPS came in at -$2.45 .
Earnings released on 9 Aug 2024
EPS came in at -$2.42 .
Stock split effective on 28 May 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2024
EPS came in at -$2.85 .
Earnings released on 21 Mar 2024
EPS came in at -$0.71 surpassing the estimated -$1.25 by +43.20%.
Stock split effective on 21 Nov 2023
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 Nov 2023
EPS came in at -$41.23 falling short of the estimated -$18.74 by -120.01%.
Earnings released on 11 Aug 2023
EPS came in at -$0.16 matching the estimated -$0.16.
Earnings released on 22 May 2023
EPS came in at -$0.23 falling short of the estimated -$0.11 by -109.09%.
Earnings released on 30 Dec 2022
EPS came in at -$57.53 .
Earnings released on 29 Sept 2022
EPS came in at -$69.18 .
Earnings released on 29 Jun 2022
EPS came in at -$53.04 .
Earnings released on 30 Mar 2022
EPS came in at -$104.35 .
Earnings released on 30 Dec 2021
EPS came in at $80.94 .
Earnings released on 29 Sept 2021
EPS came in at -$31.09 .
CNTN Stock Performance
Access detailed CNTN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
